2019
DOI: 10.1016/j.ijpharm.2019.118484
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(17 citation statements)
references
References 19 publications
3
14
0
Order By: Relevance
“…The hydrophobic monolayer has an occlusive effect that prevents water evaporation, allowing a potentiation of local antibacterial activity while supporting the skin's moisture level. Both SLN and NLC also display good biocompatibility and tolerability and are currently widely used in skincare products [108][109][110].…”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%
“…The hydrophobic monolayer has an occlusive effect that prevents water evaporation, allowing a potentiation of local antibacterial activity while supporting the skin's moisture level. Both SLN and NLC also display good biocompatibility and tolerability and are currently widely used in skincare products [108][109][110].…”
Section: Future Perspectives and Conclusionmentioning
confidence: 99%
“…Among them, nanostructured lipid carriers (NLCs) have gained attention as promising second-generation of lipid-based delivery systems, allowing e cient drug delivery to target tissues. In particular, NLCs are capable of exerting a local effect when topically administered on a wound, as demonstrated by Vairo et al (23). Moreover, antimicrobial activity can be increased when anti-Pseudomonas antibiotics are loaded in these nanoparticles by enhancing the interaction between the bio lm-bearing colony and the antibiotics.…”
Section: Introductionmentioning
confidence: 93%
“…The topical applications of lipid-based nanoparticles have been explored in depth due to the occlusive nature of formulations. In vivo and ex vivo biodistribution studies of NLCs radiolabeled with 99 mTc were performed by Vairo et al Their developed NLCs were safe, remained on the wounds and were not absorbed for at least 24 h [ 141 ].…”
Section: Lipid-based Delivery Systems In Regenerative Medicinementioning
confidence: 99%